Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Industry Support & Quality Initiatives

Kenneth Saag, MD, MSc, Gary Bryant, MD, Brian Feldman, MD, MSc, David Felson, MD, Liana Fraenkel, MD, MPH, Salahuddin Kazi, MBBS, and Kristen McNiff, MPH  |  Issue: July 2010  |  

Determining and managing levels of individual conflict and perceived conflict of interest are the subjects of ongoing discussion by the ACR, the medical profession, and society as a whole. The Council of Medical Specialty Societies (CMSS) took a significant step into this debate with the publication of the CMSS Code for Interactions with Companies in April.3 The code addresses guideline development in a comprehensive section. The code, along with other recent publications on this topic, will be among the sources that the ACR will review and analyze as we seek up-to-date policies that minimize the potential for and perception of conflict and allow members to meaningfully and fully contribute to their professional society.4

There is a great need for our patients, colleagues in medicine, and policy makers to perceive ACR-developed and ACR-endorsed products as free from industry influence. Strong ACR policies regarding industry support are a step in the right direction for rheumatology.

ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Saag is chair of the QOC, Dr. Bryant is co-chair of the QOC Quality Measures Subcommittee, Dr. Feldman is on the QOC Criteria Subcommittee, Dr. Felson is on the QOC Criteria Subcommittee, Dr. Fraenkel is chair of the QOC Guidelines Subcommittee, Dr. Kazi is co-chair of the QOC Quality Measures Subcommittee, and Kristen McNiff is vice president of the ACR Registry, Quality, and Healthcare Informatics Department.

References

  1. Gabriel S. Physician–industry relationships. The Rheumatologist. 2009;7:5,7.
  2. Licurse A, Barber E, Joffe S, Gross C. The impact of disclosing financial ties in research and clinical care: A systematic review. Arch Intern Med. 2010;170:675-682.
  3. Council of Medical Specialty Societies. Code for Interactions with Companies. April 2010. Available at: www.cmss.org/uploadedFiles/Site/CMSS_Policies/CMSS%20Code%20for%20Interactions%20with%20Companies%204-19-10.pdf. Accessed June 11, 2010.
  4. Guyatt G, Akl EA, Hirsh J, et al. The vexing problem of guidelines and conflict of interest: A potential solution. Ann Intern Med. 2010;152:738-741.

Related Articles

    ACR Quality of Care Committee Impresses with Its Recent Productivity

    Over the past 18 months, the ACR’s Quality of Care (QOC) Committee has helped produce an impressive number of resources that will help rheumatologists deliver the best possible care. Working through specific projects supervised under its Criteria, Guideline, Guidance, and Quality Measure subcommittees, the QOC Committee has developed new sets of disease criteria, clinical guidelines,…

    The New Guidance Subcommittee Gives ACR More Document Flexibility

    The ACR publishes multiple types of documents to provide guidance for its members, but some potentially beneficial topics have not fit neatly into existing production pathways. To answer the need, the ACR has formed a Guidance Subcommittee to the Quality of Care (QOC) Committee. This will allow the ACR to adapt more nimbly, when appropriate,…

    New ACR/ARP Committee Members Are Ready to Work

    Volunteering is a great way to give back and can be truly meaningful. Myriad worthwhile causes exist, so it can be hard to choose among them, but donating time to ACR and ARP committees helps promote rheumatology practice and brings awareness to rheumatic diseases. The College relies on volunteers to help achieve strategic priorities, promote…